Keller ISD, TX's Ongoing Significant Economic Development Lifts Rating To 'A+' Jan 07

  • ID: 1784743
  • January 2007
  • Standard & Poors
1 of 3

DALLAS (Standard & Poor's) Jan. 23, 2007--Standard & Poor's Ratings Services raised its Issuer Credit Rating (ICR) one notch to 'A+' from 'A' on Keller Independent School District (ISD), Texas' GO debt based on the district's ongoing significant economic development. The outlook remains stable. In addition, the rating service assigned its 'A+' ICR, and stable outlook, to the district's $142.25 million series 2007 unlimited-tax GO school building bonds. The ICR reflects the district's access to the Dallas-Fort Worth metropolitan area, above-average income and wealth levels, and strong financial position. "The district's high direct and overall net debt burden and slow debt amortization are factors that will likely limit the rating's further upward movement," said Standard & Poor's credit analyst James...

Companies mentioned in this report are:
- Keller Indpt Sch Dist

Action: Affirmed
Action: New Rating
Action: Outlook: Stable
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Keller Indpt Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.